Table 1 Baseline characteristics of the enrolled patients
EUS-first (n = 44) | ERCP-first (n = 60) | P value | |
|---|---|---|---|
Age (years) mean ± SD | 59.04 ± 15.82 | 62.82 ± 19.89 | 0.30 |
Sex (male/female) | 24/20 | 37/23 | 0.47 |
AST (U/L) mean ± SD | 334.48 ± 274.56 | 354.47 ± 219.62 | 0.68 |
ALT (U/L) mean ± SD | 347.59 ± 312.21 | 397.57 ± 227.73 | 0.38 |
Total bilirubin (mg/dL) mean ± SD | 3.74 ± 2.34 | 3.62 ± 1.79 | 0.77 |
ALK-P (U/L) mean ± SD | 207.55 ± 169.02 | 215.35 ± 90.18 | 0.80 |
Pancreatitis (yes/no) | (14/30) | (17/43) | 0.70 |
CBD diameter (mm) (median, IQR) | 7.0 (4.25–8.00) | 8.5 (7.0–11.0) | < 0.001 |
Naïve papilla (Yes/No) | 44/0 | 53/7 | 0.02 |
Diffcullt cannulation (%) | 0.787 | ||
Main P duct cannulation | 2 (11.8) | 12 (20) | |
Cannulation > 10 min | 1 (5.9) | 4 (6.7) | |
> 5 times trial | 0 | 1 (1.7) | |
P duct injection | 0 | 2 (3.3) | |
P duct stent (%) | 1 (5.9) | 13 (21.7) | 0.173 |
Sphincterotomy method | < 0.001 | ||
EST* | 15 | 34 | |
EPBD† | 2 | 16 | |
Pre-cut or TPS‡ | 0 | 10 | |
EUS only | 27 | 0 |